Text of MN HF 1912 (2019)
Gender dysphoria; medical assistance coverage of necessary treatment and certain prescribed drugs required.
Legislative text is a public record. Where LegiScan supplied it, the CC BY 4.0 credit applies.
Source: LegiScan. Bill data and text from LegiScan (legiscan.com), licensed CC BY 4.0 and used in modified form. LegiScan does not endorse the Trans Data Initiative. License: CC BY 4.0(opens another site). Source page(opens another site)
As introduced
1,969 characters
1.1
A bill for an act
1.2
relating to human services; requiring medical assistance to cover medically
1.3
necessary treatment of gender dysphoria and certain prescribed drugs for treatment
1.4
of gender dysphoria; amending Minnesota Statutes 2018, section 256B.0625,
1.5
subdivision 3a, by adding a subdivision.
1.6
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:
1.7
Section 1. Minnesota Statutes 2018, section 256B.0625, subdivision 3a, is amended to
1.8
read:
1.9
Subd. 3a. Sex reassignment surgery Treatment of gender dysphoria. Sex reassignment
1.10
surgery is not covered, unless medically necessary.
1.11
Sec. 2. Minnesota Statutes 2018, section 256B.0625, is amended by adding a subdivision
1.12
to read:
1.13
Subd. 13k. Treatment of gender dysphoria. Notwithstanding subdivision 13d, paragraph
1.14
(b), clause (1), the commissioner may include drugs for the treatment of gender dysphoria
1.15
within the drug formulary established under subdivision 13d if:
1.16
(1) the drug is approved for marketing by the United States Food and Drug
1.17
Administration;
1.18
(2) the dose and indication for use of the drug is recommended by a clinical guideline
1.19
or practice parameter included in the National Guideline Clearinghouse maintained by the
1.20
United States Department of Health and Human Services Agency for Healthcare Research
1.21
and Quality; and
1
Sec. 2.
REVISOR
ACS/CH
19-1186
01/02/19
State of Minnesota
This Document can be made available
in alternative formats upon request
HOUSE OF REPRESENTATIVES
H. F. No. 1912
NINETY-FIRST SESSION
Authored by Cantrell
02/28/2019
The bill was read for the first time and referred to the Committee on Health and Human Services Policy
2.1
(3) there is not another drug or regimen available within the formulary to treat the
2.2
condition.
2
Sec. 2.
REVISOR
ACS/CH
19-1186
01/02/19